HLA
BLUE

Hamilton Lane Advisors’s bluebird bio BLUE Stock Holding History

Hamilton Lane Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,154
Closed -$9.06M – 50
2015
Q2 		$9.06M Buy
+4,154
New +$8.46M 3.42% 6
2014
Q4 		– Sell
-8,510
Closed -$3.96M – 56
2014
Q3 		$3.96M Buy
+8,510
New +$3.93M 1.29% 18
2014
Q1 		– Sell
-6,842
Closed -$1.86M – 72
2013
Q4 		$1.86M Buy
+6,842
New +$1.91M 1.08% 26

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Hamilton Lane Advisors's BLUE Position: Q3 2015 in Review

Hamilton Lane Advisors sold out of bluebird bio (BLUE) in Q3 2015, closing a stake of 4,154 shares — an estimated $9.06M sold.

Hamilton Lane Advisors first reported a position in BLUE in Q4 2013 and held it in 3 quarters. The position peaked at $9.06M in Q2 2015. 192 funds tracked by Wall St. Rank hold BLUE as of Q3 2015.

  • Hamilton Lane Advisors reported no remaining bluebird bio position as of Q3 2015 after selling out during the quarter.
  • Hamilton Lane Advisors sold 4,154 bluebird bio shares in Q3 2015, an estimated $9.06M.
  • Hamilton Lane Advisors first reported a position in bluebird bio in Q4 2013 and held it in 3 quarters.
  • Hamilton Lane Advisors's bluebird bio position peaked at $9.06M in Q2 2015.
  • 192 funds tracked by Wall St. Rank held bluebird bio as of Q3 2015.

Based on Hamilton Lane Advisors's 13F filing for Q3 2015, filed 19 Oct 2015.